Abstract

Conalbumin (CA)-specific type 2 helper T cell (Th2) clone, D10G4.1 (D10) produces IL4 when stimulated with varying doses of TNP-CA in the presence of mitomycin C-treated C3H spleen cells or purified B cells as antigen-presenting cells (APC). The production of IL4 was assessed by bioassay and by expression of IL4 mRNA. IL4 production reached maximum at 100 μg/ml of TNP-CA, whereas 1 μg/ml of the antigen induced less than 10% of the maximum level of IL4. This lower level of IL4 production was augmented to the maximum level when monoclonal anti-TNP IgG 1, was added to the culture at 0.5–1 μg/ml. Anti-TNP IgE, but not anti-TNP IgM, was also effective, though IgE was 1 10 as effective as IgG 1. IgG 1 with an irrelevant specificity and F(ab') 2 of anti-TNP IgG 1 did not show augmenting effects. Moreover, the enhancement by anti-TNP IgG 1 was completely abolished by monoclonal antibody against murine FcγRII, 2.4G2. These results suggest that a low dose of the antigen complexed with IgG 1 is focused on APC by means of FcγRII, processed, and presented efficiently to the Th2 clone. On the other hand, the co-culture of D10 with normal C3H B cells in the presence of 1–100 μg/ml TNP-CA resulted in polyclonal IgE production. Anti-TNP IgG 1 markedly augmented the lower level of IgE production induced by a suboptimal dose of the antigen (1 μg/ml). This augmentation was shown to be dependent on endogenous IL4 because the enhancement was abolished by monoclonal anti-IL4 (11B11).

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.